Business

$12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL

$12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL

Xenitra LimitedJuly 26, 20264

$12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL

About this update from Xenitra Limited

Xenitra Limited has released a press release. View Attachment

View stock analysis, news, and events for Xenitra Limited

More from Xenitra Limited

Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth

August 23, 2026

$5m Offtake Agreement Expands OTC-Medicine Business

August 17, 2026

All Xenitra Limited news →